Your browser doesn't support javascript.
loading
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors.
Guidetti, Francesca; Arribas, Alberto J; Sartori, Giulio; Spriano, Filippo; Barnabei, Laura; Tarantelli, Chiara; Von Roemeling, Reinhard; Martinez, Elizabeth; Zucca, Emanuele; Bertoni, Francesco.
Afiliación
  • Guidetti F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Sartori G; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Barnabei L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Von Roemeling R; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Martinez E; Curis, Inc., Lexington, MA 02421, USA.
  • Zucca E; Curis, Inc., Lexington, MA 02421, USA.
  • Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
J Clin Med ; 12(2)2023 Jan 04.
Article en En | MEDLINE | ID: mdl-36675328

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Clin Med Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Clin Med Año: 2023 Tipo del documento: Article País de afiliación: Suiza